Aller au contenu principal
Profil bibliographique

Laura Hilton

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

4Publications signalées
28Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Asthma and respiratory diseasesChronic Obstructive Pulmonary Disease (COPD) ResearchHIV-related health complications and treatmentsHIV/AIDS Research and InterventionsHIV Research and Treatment

Les publications récentes

Accès ouvert 2025 article OpenAlex

How are HIV services in the UK and Ireland managing care home residents living with HIV?

Benjamin Moshy, Tristan Barber, Maithili Varadarajan, Marta Boffito et autres

PURPOSE: The average age of people living with HIV in Europe is rising and with it the likelihood of entering long-term care. Little is known about the characteristics of people living with HIV in care homes and how their HIV care is …

gb, ie (code pays fourni par la source)

0 citations European Geriatric Medicine
Accès ouvert 2024 article OpenAlex

Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT)

Nicholas I. Paton, Alejandro Arenas‐Pinto, Wendy Hadley, David Stacey et autres

Background: Treatment-simplification strategies are important tools for patient-centred management. We evaluated long-term outcomes from a PI monotherapy switch strategy. Methods: Eligible participants attending 43 UK treatment centres had a viral load (VL) below 50 copies/ml for at least 24 weeks on combination …

sg, gb, rs (code pays fourni par la source)

3 citations EClinicalMedicine
2011 article OpenAlex

Optimized glucuronidation of dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD

Laura Hilton, Rachel Osborne, Amy S. Kenyon, Helen Baldock et autres

‘Inhalation by design’ concepts were developed to create novel dual pharmacology β-2 agonists-M3 antagonists, for the treatment of chronic obstructive pulmonary disorder. A key feature of this work is the combination of balanced potency and pharmacological duration with optimised glucuronidation through the …

us, gb (code pays fourni par la source)

7 citations MedChemComm

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.